Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Congress
Congressional Hearing on Drug Safety: an Update from the FDA
Last week, The House Committee on Energy and Commerce, Subcommittee on Health held a hearing on “Drug Safety: An Update from the…
GAO Recommends the FDA to Strengthen Investigation Oversight
Within the Food and Drug Administration (FDA) is the Office of Criminal Investigations (OCI), which investigates individuals and…
MedPAC to Discuss New Funding Priorities for Graduate Medical Education
Expanding on their June 2009 Report “Medical education in the United States:
Supporting long-term delivery system reforms” The…
AMA Calling For End of Temporary Fix to Medicare Payments
This week, in response to the proposed 21% cut to Medicare reimbursement rates set to take effect on March 1, James…
Letters from Grassley: Questions WebMD Advertising Model
Keeping up with his busy letter-sending schedule last week, Senator Charles Grassley (R-IA) sent a letter to the WebMD Health…
President Obama’s Health Care Summit: Republican Alternatives
While health care reform has been on the backburner since the election of Republic Senator Scott Brown (R-MA) ended the Democrats…
Senate Finance Committee Staff Report On GlaxoSmithKline and The Diabetes…
Today the New York Times published some of the findings of a report conducted by the Senate Finance Committee Staff on the…
Letters from Grassley: FDA to Clarify Policies on Medical Devices
This week, Senator Charles Grassley (R-IA), ranking member of the Senate Finance Committee, issued a press release asking the Food…
When Congress Comes Calling: The Unique Rights and Wrongs of Responding to…
On Friday, February 19, 2010, the Washington Legal Foundation (WLF) is hosting a web seminar series titled “When Congress Comes…
Billy Tauzin Leaving PhRMA
Last week, Billy Tauzin, a 66-year-old cancer survivor, and former Congressman from Louisiana, announced that he would be…